Amman, June 23 (Petra) -- The Japanese embassy in Amman Sunday delivered medical equipment to the clinics of the Jordan Association for Family Planning and Protection (JAFPP) in a ceremony attended by the Japanese Ambassador to Jordan Hidenao Yanagi and president of the JAFPP Abed Mansi.

'The medical equipment are aimed to improve diagnosis procedures in the Jordan Association for Family Planning and Protection,' the embassy said in a statement.

Yanagi said: 'I sincerely hope that these"...

KARAK — His Majesty King Abdullah on Sunday visited Karak and inaugurated the expansion of new sections at the southern governorate’s public hospital.

The expansion includes catheterisation, cardiac surgery, burns and kidney stone crushing units, with the aim of improving medical services in the southern region.

During a meeting with community leaders, as part"...

Amman, June 22 (Petra)- Minister of Energy and Mineral Resources, Hala Zwati, said the fixed tax approved by the Cabinet is the penultimate stage in the oil derivatives market liberalization program, which will be followed by setting fuel price ceilings.

The government's decision to unify the tax on oil derivatives by fixing its value means that it will not rise now or in the future if prices rise, Zawati said in an interview with 'Petra'.

In regard to the assessment results of the gas"...

Amman, June 22 (Petra)-Director General of the Jordan Food and Drug Administration (JFDA), Dr. Hayel Obeidat, said the reduction of medications prices speedily is a step in favor of the citizen, adding the drug institution will not hesitate to apply the law against violators.

Speaking at a symposium hosted by 'Petra,' Obeidat said the JFDA acts as a monitoring body and protects drug test data when submitting registration to preserve the information confidentiality, as an effort for the companies'"...

Jumeirah was recognized as one of UAE’s strongest brands at the 15th annual Superbrands tribute event, held on June 18 at the Intercontinental Dubai-Festival City. Out of approximately 150 leading brands, 48 brands from the UAE were awarded Superbrand Status at the event, considered as the ‘Oscars of Branding’ by the corporate world.

Dr Waleed Achi, COO, Emirates Healthcare and officials from Emirates Hospital - Jumeirah, including"...

Integrated healthcare platform cure.fit launched its new fitness revolution centre, cult.fit in Dubai at Palm Strip Mall. Headquartered in Bengaluru India, the holistic healthcare company was founded in 2016 by Mukesh Bansal and Ankit Nagori with the aim to address preventive healthcare.

Funded by top investors like Accel Partners, Kalaari Capital, Chiratae Ventures, Ratan Tata, IDG Ventures, Pratithi Investment"...

Ferring Pharmaceuticals and WOOM today announced a collaboration, which aims to improve and shorten the fertility journeys of the one in six couples who have difficulty conceiving.1

The WOOM ovulation and fertility app, currently available in Spanish - with registered users across Spain, Mexico, Colombia, Chile, Argentina and Peru - is able to analyse a woman’s menstrual cycle, lifestyle factors and biometrics to help couples better understand"...

The National Committee Against Smoking and Tobacco held its first meeting on Monday under the chairmanship of Prime Minister Dr Omar Razzaz, the committee’s chairman, and in the presence of Her Highness Dina Mired Princess of Jordan and representatives of the World Health Organisation.

The Prime Minister stressed that the committee will combat this dangerous phenomenon and its negative impact on society, especially for young people.

Aligning with the principles set forth for the “Year of Tolerance,” Fakih IVF Fertility Center is reaching out to individuals in an effort to promote the values of tolerance.

The campaign titled “Positive Mind. Positive Vibes. Positive Results,” stems out from the center’s support of our ruler’s vision of creating a more tolerant nation. As part of the initiative patients will be offered a generous discount on"...

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα, being studied in patients with advanced solid tumors. The Phase 1 study is a dose finding study of BI 765063, a myeloid checkpoint inhibitor, administered as a single agent and in combination with Boehringer Ingelheim’s monoclonal"...